These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16193663)

  • 1. [Nootrope activity of ovarian estrogens].
    Arushanian EB
    Eksp Klin Farmakol; 2005; 68(4):63-9. PubMed ID: 16193663
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-L-carnitine. Monograph.
    Altern Med Rev; 2010 Apr; 15(1):76-83. PubMed ID: 20359271
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epiphyseal hormone melatonin: a new nootrope?].
    Arushunian EB
    Eksp Klin Farmakol; 2005; 68(3):74-9. PubMed ID: 16047688
    [No Abstract]   [Full Text] [Related]  

  • 5. [Final IQWiG to Ginkgo biloba].
    Winckler T
    Pharm Unserer Zeit; 2009; 38(5):454-61. PubMed ID: 19711323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sex hormones as putative risk factors].
    Asada T; Ishijima M
    No To Shinkei; 2000 Mar; 52(3):203-8. PubMed ID: 10769840
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogens and aging.
    Tuppurainen M; Saarikoski S
    Adv Neurol; 2003; 91():101-6. PubMed ID: 12442668
    [No Abstract]   [Full Text] [Related]  

  • 9. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 10. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs for Alzheimer disease.
    Can Fam Physician; 2005 Nov; 51(11):1485. PubMed ID: 16353830
    [No Abstract]   [Full Text] [Related]  

  • 12. Donepezil-induced nightmares in mild cognitive impairment.
    Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
    [No Abstract]   [Full Text] [Related]  

  • 13. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
    Vellas B; Andrieu S; Cantet C; Dartigues JF; Gauthier S
    J Nutr Health Aging; 2007; 11(4):338-41. PubMed ID: 17653494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
    Contin M; Martinelli P; Albani F; Scaglione C; Avoni P; Rizzo G; Baruzzi A
    Clin Neuropharmacol; 2007; 30(2):122-4. PubMed ID: 17414945
    [No Abstract]   [Full Text] [Related]  

  • 16. [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].
    Sorokina ND; Selitskiĭ GV; Kositsyn NS
    Fiziol Cheloveka; 2007; 33(3):35-9. PubMed ID: 17619614
    [No Abstract]   [Full Text] [Related]  

  • 17. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 18. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
    Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
    Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
    Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
    [No Abstract]   [Full Text] [Related]  

  • 20. Expanded use of Aricept.
    FDA Consum; 2007; 41(1):3. PubMed ID: 17354281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.